| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.16e-05 | 507 | 38 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.16e-05 | 507 | 38 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 4.64e-05 | 210 | 38 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.37e-04 | 264 | 38 | 5 | GO:0019902 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.29e-04 | 18 | 38 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.58e-03 | 31 | 38 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | ephrin receptor binding | 1.69e-03 | 32 | 38 | 2 | GO:0046875 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.79e-03 | 33 | 38 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.88e-03 | 129 | 38 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.89e-03 | 279 | 38 | 4 | GO:0005096 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 1.90e-03 | 34 | 38 | 2 | GO:0050750 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 2.50e-03 | 39 | 38 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 2.63e-03 | 40 | 38 | 2 | GO:0140662 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.95e-03 | 151 | 38 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 4.08e-03 | 50 | 38 | 2 | GO:0003755 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 4.55e-03 | 1418 | 38 | 8 | GO:0030234 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 4.57e-03 | 53 | 38 | 2 | GO:0016859 | |
| GeneOntologyMolecularFunction | isomerase activity | 5.77e-03 | 192 | 38 | 3 | GO:0016853 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.87e-03 | 614 | 38 | 5 | GO:0140657 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 9.73e-06 | 73 | 38 | 4 | GO:0050879 | |
| GeneOntologyBiologicalProcess | actin rod assembly | 9.90e-06 | 3 | 38 | 2 | GO:0031247 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DIAPH2 CACNA1A HRG MYCBP2 UBE3A DYNC2LI1 FKBP4 SIPA1L1 ITPR1 | 1.76e-05 | 846 | 38 | 9 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DIAPH2 CACNA1A HRG MYCBP2 UBE3A DYNC2LI1 FKBP4 SIPA1L1 ITPR1 | 2.06e-05 | 863 | 38 | 9 | GO:0031344 |
| GeneOntologyBiologicalProcess | neuromuscular process | 5.53e-05 | 225 | 38 | 5 | GO:0050905 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 8.82e-05 | 803 | 38 | 8 | GO:0030036 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 1.10e-04 | 611 | 38 | 7 | GO:0030003 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 1.11e-04 | 612 | 38 | 7 | GO:0010975 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.23e-04 | 622 | 38 | 7 | GO:0006873 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 2.12e-04 | 912 | 38 | 8 | GO:0030029 | |
| GeneOntologyBiologicalProcess | insulin processing | 2.16e-04 | 12 | 38 | 2 | GO:0030070 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 2.65e-04 | 705 | 38 | 7 | GO:0055080 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 2.78e-04 | 69 | 38 | 3 | GO:0050881 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 2.93e-04 | 717 | 38 | 7 | GO:0050801 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 2.95e-04 | 957 | 38 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | regulation of sulfur metabolic process | 4.42e-04 | 17 | 38 | 2 | GO:0042762 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.43e-06 | 46 | 38 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.94e-05 | 88 | 38 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 5.37e-05 | 114 | 38 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum lumen | 1.15e-04 | 9 | 38 | 2 | GO:0033018 | |
| GeneOntologyCellularComponent | endoplasmic reticulum chaperone complex | 2.48e-04 | 13 | 38 | 2 | GO:0034663 | |
| GeneOntologyCellularComponent | sperm plasma membrane | 7.26e-04 | 22 | 38 | 2 | GO:0097524 | |
| HumanPheno | Gaze-evoked horizontal nystagmus | 2.02e-05 | 18 | 16 | 3 | HP:0007979 | |
| Domain | Grip | 1.97e-04 | 11 | 36 | 2 | SM00755 | |
| Domain | GRIP | 1.97e-04 | 11 | 36 | 2 | PF01465 | |
| Domain | Ran_BP1 | 2.36e-04 | 12 | 36 | 2 | PF00638 | |
| Domain | GRIP_dom | 2.36e-04 | 12 | 36 | 2 | IPR000237 | |
| Domain | GRIP | 2.36e-04 | 12 | 36 | 2 | PS50913 | |
| Domain | RANBD1 | 2.36e-04 | 12 | 36 | 2 | PS50196 | |
| Domain | RanBD | 2.78e-04 | 13 | 36 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 2.78e-04 | 13 | 36 | 2 | IPR000156 | |
| Domain | HATPase_c | 5.42e-04 | 18 | 36 | 2 | SM00387 | |
| Domain | HATPase_c | 6.05e-04 | 19 | 36 | 2 | PF02518 | |
| Domain | - | 6.72e-04 | 20 | 36 | 2 | 3.30.565.10 | |
| Domain | TPR_1 | 6.89e-04 | 90 | 36 | 3 | PF00515 | |
| Domain | TPR_1 | 6.89e-04 | 90 | 36 | 3 | IPR001440 | |
| Domain | HATPase_C | 7.41e-04 | 21 | 36 | 2 | IPR003594 | |
| Domain | ZnMc | 1.42e-03 | 29 | 36 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 1.42e-03 | 29 | 36 | 2 | IPR006026 | |
| Domain | TPR-contain_dom | 2.99e-03 | 150 | 36 | 3 | IPR013026 | |
| Domain | Growth_fac_rcpt_ | 3.33e-03 | 156 | 36 | 3 | IPR009030 | |
| Domain | TPR_REGION | 3.90e-03 | 165 | 36 | 3 | PS50293 | |
| Domain | TPR | 3.90e-03 | 165 | 36 | 3 | PS50005 | |
| Domain | CUB | 4.01e-03 | 49 | 36 | 2 | PF00431 | |
| Domain | CUB | 4.18e-03 | 50 | 36 | 2 | SM00042 | |
| Domain | - | 4.51e-03 | 52 | 36 | 2 | 2.60.120.290 | |
| Domain | CUB | 4.68e-03 | 53 | 36 | 2 | PS01180 | |
| Domain | CUB_dom | 5.39e-03 | 57 | 36 | 2 | IPR000859 | |
| Domain | SH3_domain | 8.65e-03 | 220 | 36 | 3 | IPR001452 | |
| Domain | PH_dom-like | 8.83e-03 | 426 | 36 | 4 | IPR011993 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.30e-05 | 22 | 30 | 3 | M39795 | |
| Pubmed | CACNA1A RTN3 HSP90B1 HSP90B2P RGPD8 MYCBP2 UBE3A PDK1 SIPA1L1 ITPR1 | 2.80e-07 | 1139 | 38 | 10 | 36417873 | |
| Pubmed | Pigmentation-related genes and their implication in malignant melanoma susceptibility. | 4.34e-07 | 14 | 38 | 3 | 19320733 | |
| Pubmed | Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. | 1.16e-06 | 2 | 38 | 2 | 22649033 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 19965672 | ||
| Pubmed | Essential role of the molecular chaperone gp96 in regulating melanogenesis. | 1.16e-06 | 2 | 38 | 2 | 24024552 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12244140 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15034032 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 2546060 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 10839811 | ||
| Pubmed | The endoplasmic reticulum chaperone BiP is a closure-accelerating cochaperone of Grp94. | 1.16e-06 | 2 | 38 | 2 | 35078937 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22223641 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15107540 | ||
| Pubmed | Induction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation. | 1.16e-06 | 2 | 38 | 2 | 23874845 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12805368 | ||
| Pubmed | Mapping of the genes for human endoplasmic reticular heat shock protein gp96/grp94. | 1.16e-06 | 2 | 38 | 2 | 8460400 | |
| Pubmed | Chromosomal assignment of the gene encoding the mouse tumor rejection antigen gp96. | 1.16e-06 | 2 | 38 | 2 | 3410508 | |
| Pubmed | An essential role for ATP binding and hydrolysis in the chaperone activity of GRP94 in cells. | 1.16e-06 | 2 | 38 | 2 | 19553200 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 21358806 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 36516930 | ||
| Pubmed | Radicicol-sensitive peptide binding to the N-terminal portion of GRP94. | 1.16e-06 | 2 | 38 | 2 | 12189140 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 23740953 | ||
| Pubmed | GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection. | 1.16e-06 | 2 | 38 | 2 | 34061598 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11265634 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 19914304 | ||
| Pubmed | HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling. | 1.16e-06 | 2 | 38 | 2 | 36198833 | |
| Pubmed | gp96 expression in neutrophils is critical for the onset of Escherichia coli K1 (RS218) meningitis. | 1.16e-06 | 2 | 38 | 2 | 22109526 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 23859598 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 15128793 | ||
| Pubmed | HSP100, a 100-kDa heat shock protein, is a Ca2+-calmodulin-regulated actin-binding protein. | 1.16e-06 | 2 | 38 | 2 | 2768254 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 16054593 | ||
| Pubmed | GRP94 promotes muscle differentiation by inhibiting the PI3K/AKT/mTOR signaling pathway. | 1.16e-06 | 2 | 38 | 2 | 31025379 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 21647226 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 26396174 | ||
| Pubmed | Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors. | 1.16e-06 | 2 | 38 | 2 | 34283809 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 9858596 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 3612811 | ||
| Pubmed | Endoplasmic Reticulum Chaperone Glucose-Regulated Protein 94 Is Essential for Proinsulin Handling. | 1.16e-06 | 2 | 38 | 2 | 30670477 | |
| Pubmed | Chaperone gp96-independent inhibition of endotoxin response by chaperone-based peptide inhibitors. | 1.16e-06 | 2 | 38 | 2 | 22532561 | |
| Pubmed | The peptide-binding activity of GRP94 is regulated by calcium. | 1.16e-06 | 2 | 38 | 2 | 17411420 | |
| Pubmed | gp96 is a human colonocyte plasma membrane binding protein for Clostridium difficile toxin A. | 1.16e-06 | 2 | 38 | 2 | 18411291 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25220589 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 11739487 | ||
| Pubmed | 5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. | 1.16e-06 | 2 | 38 | 2 | 2438686 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 31358658 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 18340425 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27183126 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 17671676 | ||
| Pubmed | Treg suppress CTL responses upon immunization with HSP gp96. | 1.16e-06 | 2 | 38 | 2 | 19839010 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12446445 | ||
| Pubmed | GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells. | 1.16e-06 | 2 | 38 | 2 | 31395819 | |
| Pubmed | Immunolocalization and heart levels of GRP94 in the mouse during post-implantation development. | 1.16e-06 | 2 | 38 | 2 | 9363855 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 31018807 | ||
| Pubmed | Hsp90β1 knockout targeted to male germline: a mouse model for globozoospermia. | 1.16e-06 | 2 | 38 | 2 | 21208614 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22854046 | ||
| Pubmed | Identification of gp96 as a novel target for treatment of autoimmune disease in mice. | 1.16e-06 | 2 | 38 | 2 | 20352117 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 12461080 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 27417661 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22292497 | ||
| Pubmed | Gp96 deficiency affects TLR4 functionality and impairs ERK and p38 phosphorylation. | 1.16e-06 | 2 | 38 | 2 | 29447283 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 8179819 | ||
| Pubmed | Visualization of conformational transition of GRP94 in solution. | 1.16e-06 | 2 | 38 | 2 | 37949474 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 23553495 | ||
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 22876182 | ||
| Pubmed | CACNA1A GRB2 RTN3 HRG HSP90B1 HSP90B2P AP3B1 MYO7A PDK1 SIPA1L1 | 2.22e-06 | 1431 | 38 | 10 | 37142655 | |
| Pubmed | ANKRD11 GRB2 RTN3 HSP90B1 AP3B1 MYCBP2 PDK1 NSRP1 FKBP4 ITPR1 | 3.13e-06 | 1487 | 38 | 10 | 33957083 | |
| Pubmed | Essential roles of grp94 in gut homeostasis via chaperoning canonical Wnt pathway. | 3.48e-06 | 3 | 38 | 2 | 23572575 | |
| Pubmed | Tyrosine phosphorylation activates surface chaperones facilitating sperm-zona recognition. | 3.48e-06 | 3 | 38 | 2 | 15252132 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 14570872 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 21048103 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22724016 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19000718 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 1692794 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 20410492 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19158397 | ||
| Pubmed | Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. | 3.48e-06 | 3 | 38 | 2 | 11884472 | |
| Pubmed | GP96 is a GARP chaperone and controls regulatory T cell functions. | 3.48e-06 | 3 | 38 | 2 | 25607841 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 30787103 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17525271 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 14668429 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 18509083 | ||
| Pubmed | Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis. | 3.48e-06 | 3 | 38 | 2 | 24322981 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 3036833 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 24027047 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 22554506 | ||
| Pubmed | Differential requirement of GRP94 and GRP78 in mammary gland development. | 3.48e-06 | 3 | 38 | 2 | 24953136 | |
| Pubmed | GRP94 is an IGF-1R chaperone and regulates beta cell death in diabetes. | 3.48e-06 | 3 | 38 | 2 | 38811543 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 26365983 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 24808359 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 21576699 | ||
| Pubmed | Estrogenic regulation of murine uterine 90-kilodalton heat shock protein gene expression. | 3.48e-06 | 3 | 38 | 2 | 2796999 | |
| Pubmed | GRP94 regulates M1 macrophage polarization and insulin resistance. | 3.48e-06 | 3 | 38 | 2 | 32208002 | |
| Pubmed | Gut homeostasis and regulatory T cell induction depend on molecular chaperone gp96 in CD11c+ cells. | 3.48e-06 | 3 | 38 | 2 | 28526855 | |
| Pubmed | Sex-Related Differences in Murine Models of Chemically Induced Pulmonary Fibrosis. | 3.48e-06 | 3 | 38 | 2 | 34072833 | |
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 34943901 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 19125190 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 17294405 | ||
| Pubmed | 3.48e-06 | 3 | 38 | 2 | 16601230 | ||
| Pubmed | Stimulation of CK2-dependent Grp94 phosphorylation by the nuclear localization signal peptide. | 3.48e-06 | 3 | 38 | 2 | 21739154 | |
| Pubmed | 3.87e-06 | 28 | 38 | 3 | 25332179 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 23572582 | ||
| Interaction | RGPD8 interactions | 1.12e-05 | 74 | 38 | 4 | int:RGPD8 | |
| Interaction | TTC23L interactions | 1.56e-05 | 26 | 38 | 3 | int:TTC23L | |
| Interaction | GCNA interactions | 3.45e-05 | 5 | 38 | 2 | int:GCNA | |
| Interaction | CCDC74A interactions | 3.88e-05 | 35 | 38 | 3 | int:CCDC74A | |
| Interaction | SPRY1 interactions | 5.57e-05 | 111 | 38 | 4 | int:SPRY1 | |
| Interaction | MIA2 interactions | 5.97e-05 | 113 | 38 | 4 | int:MIA2 | |
| Interaction | ECI2 interactions | 6.61e-05 | 116 | 38 | 4 | int:ECI2 | |
| Interaction | RGPD3 interactions | 9.47e-05 | 47 | 38 | 3 | int:RGPD3 | |
| Cytoband | 2q13 | 1.47e-03 | 68 | 38 | 2 | 2q13 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.60e-04 | 115 | 24 | 3 | 769 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.39e-02 | 718 | 24 | 4 | 28 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP | 8.79e-06 | 200 | 37 | 5 | M6032 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.92e-05 | 432 | 37 | 6 | M41149 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 3.19e-05 | 656 | 37 | 7 | M18979 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 5.57e-05 | 294 | 37 | 5 | M41112 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.30e-04 | 184 | 37 | 4 | M9005 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.69e-04 | 856 | 37 | 7 | M4500 | |
| Coexpression | GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN | 1.72e-04 | 198 | 37 | 4 | M5346 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN | 1.75e-04 | 199 | 37 | 4 | M6172 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP | 1.75e-04 | 199 | 37 | 4 | M5694 | |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN | 1.78e-04 | 200 | 37 | 4 | M9477 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP | 1.78e-04 | 200 | 37 | 4 | M6356 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 1.78e-04 | 200 | 37 | 4 | M9133 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN | 1.78e-04 | 200 | 37 | 4 | M7353 | |
| Coexpression | GSE7460_TCONV_VS_TREG_LN_UP | 1.78e-04 | 200 | 37 | 4 | M5673 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP | 1.78e-04 | 200 | 37 | 4 | M8705 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP | 1.78e-04 | 200 | 37 | 4 | M4323 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | 1.83e-04 | 379 | 37 | 5 | M1885 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_MATURE_ALPHA_BETA_T_CELL_AGEING | 1.98e-04 | 612 | 37 | 6 | MM3804 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 162 | 38 | 4 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-05 | 193 | 38 | 4 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 2.34e-05 | 197 | 38 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-05 | 198 | 38 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.48e-05 | 200 | 38 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 200 | 38 | 4 | fc28f71ca1cd0fdae66009ae5afe175d22f2bd8c | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.48e-05 | 200 | 38 | 4 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Drug | o463 | 8.13e-06 | 3 | 38 | 2 | CID000075311 | |
| Drug | PNU-0251126 [267429-19-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.62e-05 | 192 | 38 | 5 | 4711_UP | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.75e-05 | 195 | 38 | 5 | 3246_UP | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 1.75e-05 | 195 | 38 | 5 | 3135_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A | 1.79e-05 | 196 | 38 | 5 | 2113_DN | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.79e-05 | 196 | 38 | 5 | 2630_DN | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; HL60; HT_HG-U133A | 1.83e-05 | 197 | 38 | 5 | 2994_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.83e-05 | 197 | 38 | 5 | 2233_DN | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 1.88e-05 | 198 | 38 | 5 | 6073_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; ssMCF7; HG-U133A | 1.93e-05 | 199 | 38 | 5 | 373_UP | |
| Drug | C mu | 4.05e-05 | 6 | 38 | 2 | CID000008800 | |
| Disease | male infertility due to globozoospermia (implicated_via_orthology) | 1.37e-06 | 2 | 35 | 2 | DOID:0112312 (implicated_via_orthology) | |
| Disease | Epilepsy, Cryptogenic | 1.27e-04 | 82 | 35 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.27e-04 | 82 | 35 | 3 | C0751111 | |
| Disease | Aura | 1.27e-04 | 82 | 35 | 3 | C0236018 | |
| Disease | Neurodevelopmental Disorders | 1.84e-04 | 93 | 35 | 3 | C1535926 | |
| Disease | Bipolar Disorder | 2.35e-04 | 477 | 35 | 5 | C0005586 | |
| Disease | Epilepsy | 2.94e-04 | 109 | 35 | 3 | C0014544 | |
| Disease | Epileptic encephalopathy | 5.82e-04 | 30 | 35 | 2 | C0543888 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.77e-04 | 152 | 35 | 3 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KFFHCTDESKEFEKD | 1401 | O00555 | |
| KAYNSDFEESDEFKL | 311 | Q76B58 | |
| SFTYEYEDSKQKSDK | 656 | Q6UB99 | |
| KAAEFSKKFDEEFTA | 496 | O60879 | |
| FKAHFFSDKDECSKD | 696 | P13497 | |
| SAKKFYSESEEEEDS | 671 | O00203 | |
| EFDDKEAFVTSAYKK | 136 | Q9H0G5 | |
| CSYSKKSHFDFEEED | 206 | Q14644 | |
| TSGDFEKDDDAYKTE | 1016 | Q99666 | |
| TSGDFEKDDDAYKTE | 1016 | O14715 | |
| DKSAEDAKAIYDFTD | 126 | Q15118 | |
| VSDKEKKKTYFFAAD | 391 | P09238 | |
| EYKAFCKSFSKESDD | 11 | Q58FF3 | |
| ALEKYKEENDDFASF | 161 | P04196 | |
| TEDKKSEKFFKVFYD | 1856 | Q14643 | |
| IKEYKDSFSNEKFDF | 1231 | O75882 | |
| SKYDVFQDFESEKRK | 186 | Q8TCX1 | |
| KYDFKATADDELSFK | 6 | P62993 | |
| EEDEYKAFYKSFSKE | 351 | P14625 | |
| AAKNVSYKEDDDFET | 226 | O14647 | |
| FKSKDSEHYKAFEDA | 186 | P31415 | |
| QKFFKYSVDEKSDKE | 181 | Q9UKA1 | |
| KFDSSLDRKDKFSFD | 66 | Q02790 | |
| FEAKSTSDEAFFKHK | 436 | Q9NSC2 | |
| EDKDEKSSIYESDFQ | 146 | Q96PC5 | |
| IIDKAAFDKEFKDSY | 251 | O95197 | |
| AFDKEFKDSYKESTD | 256 | O95197 | |
| SEEEAFDFFKYLDAK | 211 | Q9H0K6 | |
| SFFDLLKGYKDDKSD | 221 | O43166 | |
| SDDYFSDKGAAKEEK | 451 | Q5VXU9 | |
| LETASDYVKDDKASF | 2121 | O75592 | |
| DVYFVSESFEDAKEK | 371 | P17752 | |
| KYFDNKDDDSDTETS | 51 | Q9UID6 | |
| DKDYTFFKVETENKF | 461 | Q05086 | |
| AKSKFEYVRDFEADD | 31 | Q9NWX6 | |
| RSKAFDDIAKYFSKE | 21 | Q7RTT6 | |
| EKTFKYDQFDESSVE | 131 | Q14586 | |
| DEYKKSFTDVFNFDL | 151 | Q14588 | |
| EDEEDLSEYKFAKFA | 991 | Q13402 |